Long-Term Follow-Up of Renal Function in Children after Liver Transplantation-A Single Center Retrospective Study

Grzegorz Kowalewski1, Piotr Kaliciński1, Marek Stefanowicz1

  • 1Department of Pediatric Surgery and Organ Transplantation, Children's Memorial Health Institute, 04-730 Warsaw, Poland.

Insights

Chronic kidney disease (CKD) is a significant risk after pediatric liver transplantation (LT). Maintaining high tacrolimus levels increased microalbuminuria, a key CKD indicator, highlighting the need for vigilant patient monitoring.

Area of Science:

  • Pediatric Nephrology
  • Transplantation Medicine
  • Immunosuppression Therapy

Background:

  • Chronic kidney disease (CKD) is a frequent complication following liver transplantation (LT).
  • Prevalence of CKD in pediatric LT recipients varies with immunosuppression and era.
  • Long-term outcomes require further investigation, especially with modern treatments.

Purpose of the Study:

  • To assess the incidence and risk factors of CKD in pediatric LT patients.
  • To evaluate the association between tacrolimus levels and renal function.
  • To determine the significance of microalbuminuria in predicting CKD post-LT.

Main Methods:

  • Retrospective analysis of 61 pediatric LT patients with ≥10 years follow-up.
  • Assessment of estimated glomerular filtration rate (eGFR) and renal tubular function.
  • Monitoring of tacrolimus blood concentrations and screening for microalbuminuria.

Main Results:

  • CKD was diagnosed in 3% of patients at 12 years post-LT.
  • Tacrolimus concentrations >4 ng/mL were linked to increased microalbuminuria.
  • Microalbuminuria was identified as a risk factor for CKD development.

Conclusions:

  • Regular, comprehensive assessment is crucial for pediatric LT patients in long-term follow-up.
  • Monitoring microalbuminuria aids in early detection of kidney damage.
  • Optimizing immunosuppression may be key to preventing CKD after LT.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
92
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
312
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
108
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
101
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
36
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
43